Dolutegravir intermediate-1 is a novel synthetic intermediate of dolutegravir extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-l infection.
[1]. Sivaram Prasad, et al. Process for the preparation of dolutegravir . WO 2016125192 A2.
















